Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective analysis reported increased tetracycline resistance in Helicobacter pylori, suggesting treatment challenges ahead in Taiwan.

Resistance to tetracycline in Helicobacter pylori increased significantly from 0% to 3.5% between 2019 and 2024, indicating treatment concerns.
Resistance rates for amoxicillin, clarithromycin, and levofloxacin showed no significant changes across the study period.
Retrospective analysis utilized the Epsilometer test to assess antibiotic susceptibility among 1,408 isolates from Taiwan.
The findings highlight regional differences in resistance profiles, underlining the complexity of treatment outcomes.

Wu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis reported increased tetracycline resistance in Helicobacter pylori, suggesting treatment challenges ahead in Taiwan.